Docket Management
Docket: 00N-1256 - Over-the-Counter Products
Comment Number: EC -80

Accepted - Volume 6

Comment Record
Commentor Ms. Michelle Walsh Date/Time 2000-06-29 19:03:17
Organization Ms. Michelle Walsh
Category Health Professional

Comments for FDA General
1. General Comments The US FDA is too overcautious in switching RX products to OTC status. Most European countires, Canada, and Austraila already allow antihistamines, muscle relaxants, low dose codeine with acetaminophen, bowel medications etc to be sold OTC and these countries have no problems with it. Here in the US were expected to run to a doctor everytime we need certain medications, which is a total waste of health insurance, time lost from work for unneeded visits. We should be able to buy these types of products OTC just like everone else does. Insurance companies are billed for overpriced office visits for 5 minute exams, that are mostly a waste of both the patients and doctors time. Theres no reason why drugs like Diflucan for yeast infections to be by RX only. Too the same goes with cough preparations with low dose codeine. Adult consumers should be able to purchase from pharmacists these products with an ID and signature proving it is a small quantity. Thank you.

EC -80